GSK
GlaxoSmithKline PLC ADR
NYSE: GSK · HEALTHCARE · DRUG MANUFACTURERS - GENERAL
$52.31
+1.77% today
Updated 2026-04-30
Market cap
$108.66B
P/E ratio
14.52
P/S ratio
3.33x
EPS (TTM)
$3.75
Dividend yield
3.26%
52W range
$34 – $61
Volume
4.7M
GlaxoSmithKline PLC ADR (GSK) Financial statements
SEC filings — annual and quarterly data.
Income statement — annual
| Item | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $23.22B | $22.74B | $24.35B | $28.37B | $28.39B | $27.39B | $26.43B | $26.50B | $23.01B | $23.92B | $27.89B | $30.19B | $30.82B | $33.75B | $24.35B | $24.70B | $29.32B | $30.33B | $31.38B | $31.95B |
| Revenue growth (YoY) | — | -2.1% | +7.1% | +16.5% | +0.1% | -3.5% | -3.5% | +0.3% | -13.2% | +4.0% | +16.6% | +8.2% | +2.1% | +9.5% | -27.8% | +1.4% | +18.7% | +3.4% | +3.5% | +1.8% |
| Cost of revenue | $5.01B | $5.21B | $6.42B | $7.38B | $7.90B | $7.65B | $7.92B | $8.59B | $7.32B | $8.85B | $9.29B | $10.34B | $10.24B | $11.86B | $7.93B | $8.16B | $9.55B | $8.56B | $9.05B | $8.77B |
| Gross profit | $18.21B | $17.53B | $17.94B | $20.99B | $20.49B | $19.74B | $18.51B | $17.92B | $15.68B | $15.07B | $18.60B | $19.84B | $20.58B | $21.89B | $16.43B | $16.53B | $19.77B | $21.76B | $22.33B | $23.18B |
| Gross margin | 78.4% | 77.1% | 73.7% | 74.0% | 72.2% | 72.1% | 70.0% | 67.6% | 68.2% | 63.0% | 66.7% | 65.7% | 66.8% | 64.9% | 67.4% | 66.9% | 67.4% | 71.8% | 71.2% | 72.5% |
| R&D | $3.46B | $3.24B | $3.68B | $4.11B | $4.46B | $4.01B | $3.98B | $3.92B | $3.45B | $3.56B | $3.63B | $4.48B | $3.89B | $4.57B | $4.79B | $5.02B | $5.49B | $6.22B | $6.40B | $7.34B |
| SG&A | $7.25B | $6.82B | $7.66B | $9.59B | $12.75B | $8.51B | $8.79B | $8.48B | $8.25B | $9.23B | $9.37B | $9.67B | $9.91B | $11.40B | $7.44B | $7.07B | $8.37B | $9.38B | $11.02B | $8.99B |
| Operating income | $7.81B | $7.94B | $7.14B | $8.43B | $3.78B | $7.81B | $7.30B | $7.03B | $3.60B | $10.32B | $2.60B | $4.09B | $5.48B | $6.96B | $5.98B | $4.36B | $6.43B | $6.75B | $4.02B | $7.01B |
| Operating margin | 33.6% | 34.9% | 29.3% | 29.7% | 13.3% | 28.5% | 27.6% | 26.5% | 15.6% | 43.1% | 9.3% | 13.5% | 17.8% | 20.6% | 24.6% | 17.6% | 21.9% | 22.2% | 12.8% | 21.9% |
| EBITDA | $8.76B | $9.22B | $8.73B | $10.24B | $5.62B | $9.88B | $8.80B | $8.80B | $5.16B | $12.89B | $4.43B | $6.18B | $7.35B | $9.22B | $8.07B | $6.49B | $8.60B | $9.08B | $6.67B | $11.62B |
| EBITDA margin | 37.7% | 40.6% | 35.9% | 36.1% | 19.8% | 36.1% | 33.3% | 33.2% | 22.4% | 53.9% | 15.9% | 20.5% | 23.8% | 27.3% | 33.1% | 26.3% | 29.3% | 29.9% | 21.3% | 36.4% |
| EBIT | $7.81B | $8.20B | $7.50B | $8.67B | $3.94B | $8.45B | $7.36B | $7.39B | $3.67B | $11.26B | $2.66B | $4.26B | $5.49B | $7.10B | $6.02B | $4.36B | $6.45B | $6.79B | $4.12B | $7.93B |
| Interest expense | $352.00M | $314.85M | $843.00M | $783.00M | $765.36M | $742.34M | $734.97M | $767.00M | $696.20M | $757.00M | $736.00M | $734.00M | $743.64M | $912.00M | $892.00M | $784.00M | $855.53M | $775.00M | $657.58M | $685.64M |
| Income tax | $2.30B | $2.22B | $1.95B | $2.22B | $1.30B | $2.24B | $1.92B | $1.02B | $137.00M | $2.15B | $877.00M | $1.36B | $754.00M | $953.00M | $67.00M | $83.00M | $707.00M | $756.00M | $526.00M | — |
| Effective tax rate | 29.9% | 29.9% | 29.7% | 28.7% | 44.4% | 29.9% | 29.9% | 15.8% | 4.7% | 20.4% | 49.0% | 47.0% | 17.2% | 17.0% | 1.2% | 1.9% | 4.5% | 13.3% | 17.0% | 0.0% |
| Net income | $5.39B | $5.22B | $4.60B | $5.53B | $1.63B | $5.26B | $4.50B | $5.44B | $2.76B | $8.42B | $912.00M | $1.53B | $3.62B | $4.64B | $5.75B | $4.38B | $14.96B | $4.93B | $2.58B | $5.59B |
| Net income growth (YoY) | — | -3.1% | -11.8% | +20.2% | -70.5% | +222.0% | -14.5% | +20.8% | -49.3% | +205.6% | -89.2% | +68.0% | +136.5% | +28.2% | +23.8% | -23.7% | +241.1% | -67.1% | -47.7% | +117.1% |
| Profit margin | 23.2% | 23.0% | 18.9% | 19.5% | 5.8% | 19.2% | 17.0% | 20.5% | 12.0% | 35.2% | 3.3% | 5.1% | 11.8% | 13.8% | 23.6% | 17.8% | 51.0% | 16.2% | 8.2% | 17.5% |